The largest database of trusted experimental protocols

4 protocols using anti human cd90

1

In Vivo Tracking of Labeled MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To track the injected MSCs in vivo, cell suspensions of human MSCs were labeled with live cell tracker CM-Dil (Cat: C7000; Thermo Fisher Scientific) and incubated in 1 µL of labeling solution per mL of Hank Balanced-Salt Solution (Sciencell, Carlsbad, CA) for 5 minutes at 37°C followed by incubation at 4°C for 15 minutes. After rinsing three times with PBS, cells were plated into a flask and left overnight in the 37°C incubator. This procedure was repeated daily for three consecutive days. A total of 1 × 105 labeled MSCs were subconjuctivally injected into the right eye of rats and 1 × 106 labeled MSCs for rabbits at two sites. An in vivo fluorescent microscope (Axiozoom; Carl Zeiss) was used to visualize the MSCs immediately after injection and weekly up to 12 weeks for rats and up to 2 weeks for rabbits. Enucleated MSC-injected rabbit eyes were cryosectioned, fixed with 4% paraformaldehyde, mounted on a slide with Vectashield mounting medium (Vector Laboratories, Burlingame, California) and imaged using a confocal microscope (LSM 710, Carl Zeiss). Additional tracking of the human MSCs was performed by immunostaining of the rabbit cornea with anti-human CD90 (from Biolegend; cat#328107, FITC antihuman CD90 [Thy1]).
+ Open protocol
+ Expand
2

Flow Cytometry and Cell Sorting for Multiple Myeloma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry and FACS experiments were performed using the BD LSR Fortessa and BD Influx Cell Sorter (BD Biosciences), respectively. The FlowJo software (https://www.flowjo.com) was used to analyze the data. All experiments included single-stained controls and were performed at the South Campus Flow Cytometry & Cellular Imaging Facility at MD Anderson Cancer Center. These following antibodies were used for quantitative flow cytometry and FACS analyses: anti-human CD138 (BioLegend, #347207, dilution 1:20); anti-mouse CD45 (BioLegend, #103116, dilution 1:20), and anti-human CD90 (BioLegend, #328118, dilution 1:20). Cell viability was assessed by DAPI staining (ThemoFisher Scientific, #62248, dilution 1:5000). The cell surface marker expression panel and the gating strategies used for the identification, quantification, and purification of MM cells by flow cytometry are described in Supplementary Table 3.
+ Open protocol
+ Expand
3

Flow Cytometric Analysis of HDPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometric analysis was carried out by entrusting a biotechnology company
(Jiamai Biotechnology Co., Ltd, Guangzhou, China). HDPSCs were washed and
collected into the flow tube. Then, PBS containing primary antibodies were added
into the sample for incubation for 2 h at room temperature in the dark:
fluorescein isothiocyanate (FITC)-conjugated anti-human Stro-1 (Proteintech,
China, FITC-65184), allophycocyanin (APC)-conjugated anti-human CD45 (Biolegend,
USA, 304011), or anti-human CD90 (Biolegend, USA, 328113) and phycoerythrin
(PE)-conjugated anti-human CD146 (Proteintech, China, PE-65181), anti-human CD29
(Biolegend, USA, 303003), anti-human CD11b (Biolegend, USA, 393111), or
anti-human CD34 (Biolegend, USA, 343505). No primary antibody incubated sample
was used as a negative control. The cell suspensions were washed twice,
resuspended in PBS, and analyzed with a Novocyte D2060R Flow Cytometer (Agilent,
USA). Novoexpress 1.5.6 (Novoexpress Software, USA) was employed for data
analysis and graph plotting.
+ Open protocol
+ Expand
4

Immunoregulatory Mechanism of CD4+ T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The materials used were L-NMMA 1 mМ (Sigma), 1-МТ (Sigma), antihuman ICAM-1 SC-107L (Santa Cruz), antihuman IDO (H-110 sc-25808, Santa Cruz), antihuman iNOS (aa 781-798, Clone 2D2-B2, MAB9502, R&D Systems), antihuman CD28 NA/LE (BD 555725), antihuman CD3 NA/LE (BD 555336), antihuman CD4 (558116, BD PharMingen), antihuman CD25 (555346, BD PharMingen), antihuman CD45 (304026, BioLegend), antihuman CD3 (300431, BioLegend), antihuman CD90 (328110, BioLegend), antihuman CD 73 (344006, BioLegend), antihuman HLA-DR (307610, BioLegend), transwell permeable membranes 0.4 μm (Greiner 665640), TRIzol® Reagent (Invitrogen, 15596-018), CyQUANT®NF (C35006, Invitrogen), Maxima SYBR Green/ROX qPCR Master Mix (2X) (K0221 Thermo Scientific), SuperScript® III Reverse Transcriptase (Thermo Scientific), and SuperSignal™ West Pico Chemiluminescent Substrate (34078 Thermo Scientific).
All donors were notified and agreed to take part in the research according to the draft Declaration on Bioethics and Human Rights (SHS/EST/05/CONF.204/3 REV) paragraph 6 items b and c. All operational procedures and protocols were strictly followed in accordance with MSU bioethics committee guidelines. All experimental protocols were conducted according to the GLP rules signed by the Ministry of Health (Order number 267 from 19 June 2003).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!